Vblastin
Vblastin Products are primarily used for
Non-Hodgkin lymphoma (NHL), Breast cancer, Kidney cancer
About Vblastin Products
Uses of Vblastin Products
Vinblastine is used in the treatment of non-Hodgkin lymphoma (NHL), breast cancer, kidney cancer and Hodgkin’s disease.
Vblastin Products side effects
Common
Side Effects of Vblastin are Hair loss, Constipation, Decreased white blood cell count (lymphocytes), High blood pressure, General discomfort, Bone pain, Tumor pain, Jaw pain.
Severe
Side Effects of Vblastin are Nausea, Vomiting, Decreased appetite, Diarrhea, Low blood platelets, Anemia (low number of red blood cells), Photosensitivity, Vesiculation of the mouth, Pharyngitis, Hemorrhagic enterocolitis, Perforated peptic ulcer, Rectal bleeding, Paresthesia (tingling or pricking sensation), Vestibular damage, Hearing loss, Loss of deep-tendon reflexes, Peripheral neuritis, Shortness of breath, Bronchospasm, Depression, Headache, Convulsion.
How Vblastin Products work
Vinblastine blocks replication of genetic material (DNA) in the cancer cells. Thus it stops the growth and multiplication of cancer cells.
Patient Concerns about Vblastin Products
Frequently asked questions about Vblastin Products
Frequently asked questions about Vinblastine
Q. Is Vblastin 10mg Injection a vesicant?
Vblastin 10mg Injection is a vesicant (irritant) and can cause damage to the blood vessels if it is not administered properly.
Q. How is Vblastin 10mg Injection administered?
Vblastin 10mg Injection is administered by intravenous route only.
Q. Does Vblastin 10mg Injection cause hair loss/infertility?
Yes, Vblastin 10mg Injection may cause hair loss/infertility.
Q. How does Vblastin 10mg Injection prevent mitosis?
Vblastin 10mg Injection prevents mitosis by inhibition of microtubule formation.
Products for Vblastin
MRP
₹225
Not Available
Substitute brands for Vblastin
Uniblastin
United Biotech Pvt Ltd
1 Product
Cytoblastin
Cipla Ltd
1 Product
Kristina V
Khandelwal Laboratories Pvt Ltd
1 Product
Hoydetain
Taj Pharma India Ltd
1 Product